The World Health Organisation recently declared the outbreak of severe acute respiratory
syndrome Coronavirus 2 disease (COVID-19) a global pandemic [1]. It is known that people …

Coronavirus disease 2019 (COVID-19) has recently emerged as a rapidly spreading
disease, affecting more than 100 countries worldwide and reaching pandemic proportions …

On 31 December 2019, several clusters of an unusual pneumonia were reported in Wuhan,
China. 1 Analysis of five patient samples identified the causative agent as the novel severe …

Aim To describe the clinical characteristics and outcomes of hospitalized COVID-19 patients
with diabetes. Methods A retrospective cross-sectional study was conducted among patients …

Abstract The COronaVirus DISease 19 (COVID-19) is a pandemic infectious disease caused
by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV …

The spread of the novel SARS-CoV-2 coronavirus (COVID-19) has reached pandemic
proportions and represents a threat for increased morbidity and mortality, globally. In many …

Background COVID-19 has a highly variable clinical presentation, ranging from
asymptomatic to severe respiratory symptoms and death. Diabetes seems to be one of the …

The advent and rapid spread of the coronavirus disease-2019 (COVID19) pandemic across
the world has focused attention on the relationship of commonly occurring comorbidities …

In December 2019, the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), causing the disease known as COVID-19, was identified in Wuhan, China. Since then …

OBJECTIVE Diabetes is one of the most distinct comorbidities of COVID-19. Here, we
describe the clinical characteristics of and outcomes in patients with diabetes in whom …